Atlas Venture Associates Opportunity I, LLC, 10% Owner at Ikena Oncology, Inc. (IKNA), bought 125,000 shares at $16.00 ($2.0M) on 2021-03-30, disclosed to the SEC on 2021-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| KYMR | SELL | 2022-12-16 | $23.9M | — | Filing → |
| GBIO | SELL | 2021-06-23 | $9.3M | — | Filing → |
| AKRO | BUY | 2019-06-25 | $4.3M | — | Filing → |